Pelthos Therapeutics Inc. PTHS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$51.59M-19.1% | -$43.32M-83.7% | -$23.58M-161% | -$9.04M-22.8% | -$7.36M+7.5% | ||
| —— | —— | —— | —— | $0— | ||
| $6.88M+26.0% | $5.46M+30.3% | $4.19M+115% | $1.95M-2.3% | $1.99M+10.8% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | $4.65M-19.3% | $5.76M+221% | $1.8M+52.2% | ||
| $4.26M-31.0% | $6.16M+129% | $2.69M+11,512% | $23.15K+118% | -$130.98K+53.7% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| $360K+39.0% | $259K-22.7% | $335K-3.0% | $345.26K+91.4% | $180.37K-73.9% | ||
| -$35.08M-55.3% | -$22.59M-32.8% | -$17.01M-783% | -$1.93M+56.5% | -$4.43M+23.5% | ||
| —— | —— | —— | —— | $0— | ||
| —— | $2.76M+33.3% | $2.07M+50.0% | $1.38M+100% | $690.25K— | ||
| —— | —— | —— | —— | $0— | ||
| $443K-36.1% | $693K-16.2% | $827K-7.4% | $893K+37.0% | $652K+21.6% | ||
| —— | —— | —— | —— | —— | ||
| $72.61M+60.2% | $45.34M— | —— | —— | —— | ||
| $32.1M+83.3% | $17.51M— | —— | —— | —— | ||
| $710K+3,637% | $19K0.0% | $19K+1.3% | $18.75K— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| $360K+39.0% | $259K-22.7% | $335K-3.0% | $345.26K+91.4% | $180.37K-73.9% | ||
| $2.59M+66.3% | $1.56M+129% | $679K— | $0— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | $0-100% | $90.75K-50.0% | $181.5K-33.3% | $272.25K-25.0% | ||
| —— | $7.39M+33.3% | $5.54M+50.0% | $3.69M+100% | $1.85M— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| —— | $0-100% | $23K-50.0% | $46K-33.3% | $69K-25.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $20.75K-50.0% | $41.5K-33.3% | $62.25K-25.0% | ||
| —— | $845K+22.9% | $687.5K+29.7% | $530K+42.3% | $372.5K+73.3% | ||
| —— | $737K-17.5% | $893.5K-14.9% | $1.05M-13.0% | $1.21M-11.5% | ||
| —— | $0-100% | $112K-50.0% | $224K-33.3% | $336K-25.0% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $369K+33.3% | $276.75K+50.0% | $184.5K+100% | $92.25K— | ||
| —— | $0-100% | $750-50.0% | $1.5K-33.3% | $2.25K-25.0% | ||
| —— | $0-100% | $6K-50.0% | $12K-33.3% | $18K-25.0% | ||
| —— | $53K+27.7% | $41.5K+38.3% | $30K+62.2% | $18.5K+164% | ||
| —— | $0-100% | $538.25K-50.0% | $1.08M-33.3% | $1.61M-25.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | -$4.98M+14.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pelthos Therapeutics Inc. generate?
- Pelthos Therapeutics Inc. (PTHS) generated -$35.1M in operating cash flow over the trailing twelve months.
- What is Pelthos Therapeutics Inc.'s free cash flow?
- After $194.0K of capital expenditures, Pelthos Therapeutics Inc.'s free cash flow was -$16.8M over the trailing twelve months.
- Where does Pelthos Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
